Partial lipodystrophy associated with juvenile dermatomyositis: Report of two cases

Pediatric Dermatology

Volumn 13, Issue 6, 1996, Pages 477-482

  Quecedo, Esther ^a   Febrer, Isabel ^a   Serrano, Gabriel ^a   Martinez Aparicio, Antonio ^a   Aliaga, Adolfo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN TISSUE; HYPERTRICHOSIS; KIDNEY FUNCTION; LIPODYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030463445     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.1996.tb00728.x     Document Type: Article

References (32)

1. Tucker LB, Sadegi-Nejed A, Schaller JG. The association of acquired lipodystrophy with juvenile dermatomyositis. Arthr Rheum 1990;33:S146.
2. Commens CJ, O'Neill P, Walker G. Dermatomyositis associated with multifocal lipoatrophy. J Am Acad Dermatol 1990;22:966-969.
3. Torrelo A, Espan̂a A, Boixeda P, Ledo A. Partial lipodystrophy and dermatomyositis. Arch Dermatol 1991;127:1846-1847.
4. Kavanagh GM, Colaco CB, Kennedy CTC. Juvenile dermatomyositis associated with partial lipoatrophy. J Am Acad Dermatol 1993;28:348-351.
5. Mitchell SW. Singular case of absence of adipose matter in upper half of the body. Am J Med Sci 1885; 90:105-107.
6. Powell EE, Searle J, Mortimer R. Steatohepatitis associated with limb lipodystrophy. Gastroenterology 1989;97:1022-1024.
7. Schifferly JA, Blanc E. Partial lipodystrophy, meningoccal meningitis and nephritis. Dermatologica 1986; 173:9-12.
8. Corbin A, Upton V, Mabry CC, et al. Diencephalic involvement in generalised lipoatrophy: rationale and treatment with the neuroleptic agent, pimozide. Acta Endocrinol 1974;77:209-220.
9. Mabry CC, Hollingsworth DR, Upton GV, et al. Pituitary-hypothalamic dysfunction in generalised lipodystrophy. J Pediatr 1973;82:625.
10. Louis L, Conn JW, Minick MC. Lipoatrophic diabetes: isolation and characterization of an insulin antagonist from urine. Metabolism 1963;12:867.
11. Jensen MD. Adrenergic regulation of lipolysis in a patient with lipoatrophy of the upper body. Mayo Clin Proc 1991;66:704-710.
12. Alarcon-Segovia D, Ramos-Niembro F. An association of partial lipodistrophy and Sjogren's syndrome. Ann Intern Med 1976:85:474-475.
13. Jasin HE. Systemic lupus erythematosus, partial lipodystrophy and hypocomplementemia. J Rheum 1979;6:43-46.
14. O'Mahony D, O'Mahony S, Whelton MJ, McKiernan J. Partial lipodistrophy in coeliac disease. Gut 1990; 31:717-718.
15. Font J, Herrero C, Bosch X, Cervera R. Ingelmo M, Mascaró JM. Systemic lupus erythematous in a patient with partial lipodystrophy. J Am Acad Dermatol 1990;22:337-340.
16. Wilson WA, Sissons JGC, Morgan O. Multiple autoimmune diseases with bilateral optic atrophy and lipodystrophy. Ann Int Med 1978;89:72-73.
17. Winkelmann RK, Padilha-Goncalves A. Connective tissue panniculitis. Arch Dermatol 1980;116:291-294.
18. Handfield-Jones SE, Stephens CJM, Mayou BJ, Black MM. The clinical spectrum of lipoatrophic panniculitis encompasses connective tissue panniculitis. Br J Dermatol 1993;129:619-624.
19. Winklemann RK. Panniculitis in connective tissue. Arch Dermatol 1983;119:336-344.
20. Magre J, Grigorescu F, Reynet C, et al. Tyrosinekinasa defect of the insulin receptor in cultured fibroblast from patients with lipoatrophic diabetes. J Clin Endocrinol Metab 1989;69:142-150.
21. Yokota A, Moller DE, Flier JS. Homozygous mutation at position 485 of the insulin receptor subunit in a patient with lipoatrophy and severe insulin resistance. Diabetes 1990;39S:235.
22. Moller DE, Cohen O, Yamaguchi Y, et al. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 1994;43:247-255.
23. Mora PF, Ramirez LC, Lender D, Raskin P. Insulin requirements in lipodystrophic diabetes. Diabet Med 1993;10:863-865.
24. Kuzuya H, Matsuura N, Sakamoto M, et al. Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 1993;42:696-705.
25. Martinez Debora MJ, Vazquez-Martul M, Ecija-Peiro JL, González-Pérez J, Lirio-Rodriguez J. Lipodistrofia parcial y glomerulonefritis membranoproliferativa. A propósito de un caso. Ann Esp Pediatr 1989;30:499-502.
26. Sissons P, Wests RJ, Fallows J, et al. The complement abnormalities of lypodystrophy. N Engl J Med 1976;294:461-465.
27. West CD. What is the risk of developing glomerulonephritis in a child with facial lipodistrophy and hypocomplementemia? Pediatr Nephrol 1989;3(2):174.
28. Fremeaux V, Maillet F, Berlan L, Kazatchkine MD. Neutralising antibodies against C3Nef in intravenous immunoglobulin. Lancet 1992;340:63-64.
29. Auffret N, Mazer JM, Belaich S, Flavian A, Binet O. Acanthosis nigricans-hyperinsulinisme: syndrome de Seip-Lawrence. Ann Dermatol Venereol 1990;117: 793-794.
30. Stuart CA, Prince MJ, Peters EJ, Meyer WJ. Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion. Obstet Gynecol 1987;69:921-925.
31. Powell EE, Searle J, Mortimer R. Steatohepatitis associated with limb lipodystrophy. Gastroenterology 1989;97:1022-1024.
32. Robertson DA, Wright R. Cirrhosis in partial lipodystrophy. Postgrad Med J 1989;65:318-320.